Fundz

Freedom Biosciences Emerges From Stealth With $10.5 Million Seed Financing To Develop Next-Generation Ketamine And Psychedelic-Based Mental Health Treatments

PRIVATEAug 23, 2022

Amount Raised

$10.5 Million

Round Type

Seed

San FranciscoBiotechnology

Description

Freedom Biosciences, a clinical-stage biotechnology platform developing next-generation viable and efficacious ketamine and psychedelic therapeutics, today emerged from stealth with $10.5 million in seed financing. MBX Capital led the round and was joined by PsyMed Ventures, Village Global and The Yale Startup, among others. The new financing will help the company advance its current lead ketamine program as well as further multiple additional exploratory programs.

Quick answer

Freedom Biosciences raised $10.5 Million in a Seed round, dated August 23, 2022. Freedom Biosciences is based in San Francisco, California, United States.

How much did Freedom Biosciences raise?
Freedom Biosciences raised $10.5 Million in a Seed round on August 23, 2022.
What does Freedom Biosciences do?
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation viable and efficacious ketamine and psychedelic therapeutics.
Where is Freedom Biosciences based and how big is it?
Freedom Biosciences is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Freedom Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Inceptor Bio raised $2.6M on October 7, 2022.
  • Pic Therapeutics raised $6.5M on October 7, 2022.
  • RadioMedix raised $40M (Series A) on October 7, 2022.
  • NewcelX raised $4M (Seed) on October 7, 2022.
  • Replimune raised $200M (Debt Financing) on October 7, 2022.
  • GenoPalate raised $6M on October 7, 2022.

Who to call at Freedom Biosciences, and when

A new round usually means Freedom Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Freedom Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Freedom Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Freedom Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Freedom Biosciences

Location

San Francisco, California, United States

About

Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation viable and efficacious ketamine and psychedelic therapeutics. The company was co-founded by Dr. John Krystal, Chair of the Department of Psychiatry at Yale University, and Dina Burkitbayeva, founder of PsyMed Ventures, alongside Hunter Bouchard and Morgan Springer. Freedom Biosciences launched from stealth in 2022 and is backed by MBX Capital, Village Global and PsyMed Ventures, among others. To learn more, visit: www.freedombio.co

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Freedom Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Freedom Biosciences's next move

See what Strategic adds

Freedom Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.